AMSBIO launches research tool suite for checkpoint inhibitors
Anglo-American life science firm AMS Biotechnology has launched new cell lines to help companies researching the PD-1/PD-L1 pathway, one of the hottest areas of immuno-oncology research.
Archives for July 4, 2016
UK's commercial DNA foundry a step on path to 'bioeconomy'
The opening of the UK's first synthetic biology foundry promises to usher in a new era of cheaper and more accessible DNA synthesis.